Edwards Lifesciences CorporationEWNYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank14
3Y CAGR-13.5%
5Y CAGR-0.8%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-13.5%/yr
vs +11.7%/yr prior
5Y CAGR
-0.8%/yr
Recent deceleration
Acceleration
-25.2pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 23.56% | -25.6% |
| 2024 | 31.68% | +3.4% |
| 2023 | 30.64% | -15.9% |
| 2022 | 36.42% | +0.8% |
| 2021 | 36.12% | +47.5% |
| 2020 | 24.49% | -18.6% |
| 2019 | 30.09% | +28.4% |
| 2018 | 23.43% | -29.4% |
| 2017 | 33.18% | +18.9% |
| 2016 | 27.91% | - |